Migralex is an over-the-counter medication for the treatment of headaches, which will become available in November of 2009. Results of the first study of Migralex were presented at the annual scientific meeting of the American Headache Society in Boston. In an open-label study 50 patients with headaches who were being treated at the NYHC compared Migralex with their usual medication. Half of the patients found Migralex better or much better than their usual treatment and 27 were willing to take it again. In 31 of 50 patients the usual medication was a triptan ( a prescription migraine medication) and in 19 it was a prescription or over-the-counter pain medication. Migralex was well tolerated, with only one patient reporting upset stomach.
